D-Lin-MC3-DMA

≥99%

Reagent Code: #61733
label
Alias (Dilinoleyl)methyl 4-(N,N-dimethylamino)butanoate; (6Z,9Z,28Z,31Z)-heptatriacont-6,9,28,31-tetraene-19-yl 4- (dimethylamino)butanoate
fingerprint
CAS Number 1224606-06-7
bubble_chart
Properties Insoluble in water, easily soluble in DMSO, methanol, ethanol. the

science Other reagents with same CAS 1224606-06-7

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 642.09 g/mol
Formula C₄₃H₇₉NO₂
thermostat Physical Properties
Boiling Point 670.2±43.0 °C(Predicted)
inventory_2 Storage & Handling
Density 0.886±0.06 g/cm3(Predicted)
Storage -20℃

description Product Description

D-Lin-MC3-DMA is an ionizable cationic lipid widely used in the development of lipid nanoparticles (LNPs) for nucleic acid delivery systems, particularly siRNA and mRNA therapeutics. It is the key lipid component in Onpattro (patisiran), the first FDA-approved LNP-siRNA drug for hereditary transthyretin-mediated amyloidosis. This compound enhances the stability, cellular uptake, and endosomal escape of nucleic acids while minimizing toxicity. It is also extensively researched for mRNA vaccines, cancer immunotherapies, and gene editing applications, advancing precision medicine through efficient and safe delivery of genetic material.

format_list_bulleted Product Specification

Test Parameter Specification
Appearance Oily liquid
Purity 98.5-100
Infrared Spectrum Conforms to Structure

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 10mg
10-20 days ฿24,880.00
inventory 100mg
10-20 days ฿239,990.00
inventory 25mg
10-20 days ฿61,660.00
inventory 5mg
10-20 days ฿15,000.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
D-Lin-MC3-DMA
No image available

D-Lin-MC3-DMA is an ionizable cationic lipid widely used in the development of lipid nanoparticles (LNPs) for nucleic acid delivery systems, particularly siRNA and mRNA therapeutics. It is the key lipid component in Onpattro (patisiran), the first FDA-approved LNP-siRNA drug for hereditary transthyretin-mediated amyloidosis. This compound enhances the stability, cellular uptake, and endosomal escape of nucleic acids while minimizing toxicity. It is also extensively researched for mRNA vaccines, cancer im

D-Lin-MC3-DMA is an ionizable cationic lipid widely used in the development of lipid nanoparticles (LNPs) for nucleic acid delivery systems, particularly siRNA and mRNA therapeutics. It is the key lipid component in Onpattro (patisiran), the first FDA-approved LNP-siRNA drug for hereditary transthyretin-mediated amyloidosis. This compound enhances the stability, cellular uptake, and endosomal escape of nucleic acids while minimizing toxicity. It is also extensively researched for mRNA vaccines, cancer immunotherapies, and gene editing applications, advancing precision medicine through efficient and safe delivery of genetic material.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...